Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XDYNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.18.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.4.1.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.16.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LW.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LP.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
ML.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.1.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-21367.3US
KP.3.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MM.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.7.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.3.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.2.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.1.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.2NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.2.6NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MA.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
KP.3.1.4NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LB.1.8NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5.81NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
CH.1.1.20NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBL.3.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MB.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LE.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XBB.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-18756.6US
LF.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
MD.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LP.3NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
JN.1.5NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
DL.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
BA.5.1.15NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.529 (Omicron)NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
EG.5.1.16NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
LE.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
XDQNSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.502NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
B.1.1.285NSC2CTGCAGATTTGGATGATTTCTCC2343.482946329485F-23117.2US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used